AstraZeneca's David Brennan - CEO Pay

AstraZeneca CEO David BrennanDavid Brennan - AstraZeneca

Total Compensation: $4.7M

Details: So much for those rumors that Brennan turned down a double-digit pay increase. The CEO's compensation bounced back from 2007's 19 percent drop, with his total 2008 salary of £2.51 million ($4.7 million) coming in at a 17 percent increase over 2007. Brennan's base salary dropped from 2007's $2 million to 1.8 million in 2008, but his bonus jumped from $2,016,000 to $2,425,000. He also received $406,000 in allowances, which included a car, relocation funds and cash for a vested performance share plan award.

AstraZeneca News:
AZ's Brennan sees "top-line" challenges ahead
AstraZeneca - Top 5 layoffs of 2008
AZ nabs more uses for Seroquel XR
AZ's Brennan tries to conceal Crestor glee
AZ's expanded China focus pays off

AstraZeneca's David Brennan - CEO Pay
Read more on

Suggested Articles

Horizon Therapeutics has notched an FDA approval for its rare eye disease med Tepezza (teprotumumab), a possible blockbuster drug in the making.

Eli Lilly has a pipeline stuffed with a host of assets and has decided it needs a new injectable drug and device plant to manufacture some of them.

After Clovis’ Rubraca snagged an FDA boost in prostate cancer last week, AZ and Merck’s rival Lynparza has matched it with a boost of its own.